Center for Scientific Review; Notice of Closed Meetings, 26105-26106 [06-4147]

Download as PDF Federal Register / Vol. 71, No. 85 / Wednesday, May 3, 2006 / Notices Suite 3208, MSC 9529, Bethesda, MD 20892– 9529, 301–496–4056. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: April 25, 2006. David Clary, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–4149 Filed 5–2–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting jlentini on PROD1PC65 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Arthritis and Musculoskeletal and Skin Diseases Advisory Council. Date: May 23, 2006. Open: 8:30 a.m. to 12 p.m. Agenda: This meeting will be open to the public to discuss administrative details relating to council business and special reports. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 6, Bethesda, MD 20892. Closed: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 6, Bethesda, MD 20892. VerDate Aug<31>2005 17:19 May 02, 2006 Jkt 208001 Contact Person: Cheryl Kitt, PhD, Director, Extramural Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 1 Democracy Blvd., Suite 800, Bethesda, MD 20892, 301–594–2463, kittc@niams.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: April 26, 2006. David Clary, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–4150 Filed 5–2–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Mesenchymal Stem Cells. Date: May 3, 2006. Time: 8:30 a.m. to 9 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 26105 Contact Person: William C. Benzing, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD 20892, (301) 435– 1254, benzingw@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group, Bioengineering, Technology and Surgical Sciences Study Section. Date: May 22–23, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Clarion Hotel Bethesda Park, 8400 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Dharam S. Dhindsa, DVM, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5110, MSC 7854, Bethesda, MD 20892, (301) 435– 1174, dhindsad@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, PAR–04– 023: Bioengineering Research Partnerships. Date: May 23, 2006. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Silver Spring, 8727 Colesville Road, Silver Spring, MD 20910. Contact Person: Behrouz Shabestari, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5106, MSC 7854, Bethesda, MD 20892, (301) 435– 2409, shabestb@csr.nih.gov. Name of Committee: Infectious Diseases and Microbiology Integrated Review Group, Pathogenic Eukaryotes Study Section. Date: June 8–9, 2006. Time: 8:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., Washington, DC 20007. Contact Person: Jean Hickman, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3194, MSC 7808, Bethesda, MD 20892, (301) 435– 1146, hickmanj@csr.nih.gov. Name of Committee: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group, Surgery, Anesthesiology and Trauma Study Section. Date: June 14–15, 2006. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Weihua Luo, PhD., M.D., Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5114, MSC 7854, Bethesda, MD 20892, (301) 435– 1170, luow@csr.nih.gov. E:\FR\FM\03MYN1.SGM 03MYN1 26106 Federal Register / Vol. 71, No. 85 / Wednesday, May 3, 2006 / Notices Name of Committee: Oncological Sciences Integrated Review Group, Chemo/Dietary Prevention Study Section. Date: June 14–16, 2006 Time: 5 p.m to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington Embassy Row, 2015 Massachusetts Ave., NW., Washington, DC 20036. Contact Person: Sally A. Mulhern, PhD., Scientific Review Administrator, Center For Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6198, MSC 7804, Bethesda, MD 20892, (301) 435– 5877, mulherns@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos.; 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393–93.396, 93.837– 93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 25, 2006. David Clary, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–4147 Filed 5–2–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings jlentini on PROD1PC65 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel Fellowship. Date: May 3, 2006. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Michael Micklin, PhD, Chief, RPHB IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3136, MSC 7759, Bethesda, MD 20892, (301) 435–1258, micklinm@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing VerDate Aug<31>2005 19:53 May 02, 2006 Jkt 208001 limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel Prion Disease Regulation and Diagnostics. Date: May 4, 2006. Time: 2 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Richard G. Kostriken, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 20892, 301–402– 4454, kostrikr@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel, Bioengineering Research Partnership. Date: May 19, 2006. Time: 2 p.m. to 3 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Pushpa Tandon, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5104, MSC 7854, Bethesda, MD 20892, 301–435– 2397, tandonp@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: BMIT and MEDI Study Sections. Date: May 21, 2006. Time: 7 p.m. to 10 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Silver Spring, 8727 Colesville Road, Silver Spring, MD 20910. Contact Person: Weihua Luo, MD, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5114, MSC 7854, Bethesda, MD 20892, (301) 435– 1170, luow@csr.nih.gov. Name of Committee: Cardiovascular Sciences Integrated Review Group, Cardiovascular Differentiation and Development Study Section. Date: June 12–13, 2006. Time: 8:30 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Maqsood A. Wani, PhD, DVM, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2114, MSC 7814, Bethesda, MD 20892, (301) 435–2270, wanimaqs@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Social Science and Population Studies RO3s, R15s, R21s and Fellowships. Date: June 16, 2006. PO 00000 Frm 00089 Fmt 4703 Sfmt 4703 Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Valerie Durrant, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD 20892, (301) 435– 3554, durrantv@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos.; 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393–93.396, 93.837– 93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: April 25, 2006. David Clary, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 06–4148 Filed 5–2–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Revocation of Certification of a Laboratory Which No Longer Meets Minimum Standards To Engage in Urine Drug Testing for Federal Agencies Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. AGENCY: SUMMARY: The Department of Health and Human Services routinely publishes a list of laboratories in the Federal Register that are currently certified to meet standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the Federal Register on April 11, 1988 (53 FR 11970), and subsequently revised in the Federal Register on June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on April 13, 2004 (69 FR 19644). This notice informs the public that the following laboratory’s certification was revoked effective February 8, 2006: Sciteck Clinical Laboratories, Inc., 317 Rutledge Road, Fletcher, North Carolina 28732. The letter describing the reasons for revoking Sciteck’s certification is available on the Internet at https:// workplace.samhsa.gov. FOR FURTHER INFORMATION CONTACT: Dr. Donna Bush, Division of Workplace Programs, SAMHSA/CSAP, Room \\ALPHA3\E\FR\FM\03MYN1.SGM 03MYN1

Agencies

[Federal Register Volume 71, Number 85 (Wednesday, May 3, 2006)]
[Notices]
[Pages 26105-26106]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-4147]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Mesenchymal Stem Cells.
    Date: May 3, 2006.
    Time: 8:30 a.m. to 9 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: William C. Benzing, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD 
20892, (301) 435-1254, benzingw@csr.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: Surgical Sciences, Biomedical Imaging and 
Bioengineering Integrated Review Group, Bioengineering, Technology 
and Surgical Sciences Study Section.
    Date: May 22-23, 2006.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Clarion Hotel Bethesda Park, 8400 Wisconsin Ave., 
Bethesda, MD 20814.
    Contact Person: Dharam S. Dhindsa, DVM, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5110, MSC 7854, Bethesda, MD 
20892, (301) 435-1174, dhindsad@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, PAR-04-023: Bioengineering Research Partnerships.
    Date: May 23, 2006.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Silver Spring, 8727 Colesville Road, Silver 
Spring, MD 20910.
    Contact Person: Behrouz Shabestari, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5106, MSC 7854, Bethesda, MD 
20892, (301) 435-2409, shabestb@csr.nih.gov.

    Name of Committee: Infectious Diseases and Microbiology 
Integrated Review Group, Pathogenic Eukaryotes Study Section.
    Date: June 8-9, 2006.
    Time: 8:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., 
Washington, DC 20007.
    Contact Person: Jean Hickman, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3194, MSC 7808, Bethesda, MD 
20892, (301) 435-1146, hickmanj@csr.nih.gov.

    Name of Committee: Surgical Sciences, Biomedical Imaging and 
Bioengineering Integrated Review Group, Surgery, Anesthesiology and 
Trauma Study Section.
    Date: June 14-15, 2006.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., 
Bethesda, MD 20814.
    Contact Person: Weihua Luo, PhD., M.D., Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5114, MSC 7854, Bethesda, MD 
20892, (301) 435-1170, luow@csr.nih.gov.


[[Page 26106]]


    Name of Committee: Oncological Sciences Integrated Review Group, 
Chemo/Dietary Prevention Study Section.
    Date: June 14-16, 2006
    Time: 5 p.m to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington Embassy Row, 2015 Massachusetts Ave., 
NW., Washington, DC 20036.
    Contact Person: Sally A. Mulhern, PhD., Scientific Review 
Administrator, Center For Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6198, MSC 7804, Bethesda, MD 
20892, (301) 435-5877, mulherns@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos.; 93.306, 
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: April 25, 2006.
David Clary,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-4147 Filed 5-2-06; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.